JWS
ALXN
Juncture Wealth Strategies’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,102
| Closed | -$328K | – | 126 |
|
|
2020
Q4 | $328K | Buy |
2,102
+236
| +13% | +$36.8K | 0.21% | 91 |
|
|
2020
Q3 | $214K | Sell |
1,866
-235
| -11% | -$27K | 0.15% | 96 |
|
|
2020
Q2 | $236K | Buy |
+2,101
| New | +$236K | 0.18% | 94 |
|
|
2020
Q1 | – | Sell |
-2,455
| Closed | -$266K | – | 103 |
|
|
2019
Q4 | $266K | Sell |
2,455
-790
| -24% | -$85.6K | 0.21% | 90 |
|
|
2019
Q3 | $318K | Sell |
3,245
-161
| -5% | -$15.8K | 0.28% | 81 |
|
|
2019
Q2 | $446K | Sell |
3,406
-200
| -6% | -$26.2K | 0.36% | 76 |
|
|
2019
Q1 | $487K | Buy |
+3,606
| New | +$487K | 0.38% | 73 |
|
|
2017
Q2 | – | Sell |
-2,406
| Closed | -$292K | – | 86 |
|
|
2017
Q1 | $292K | Sell |
2,406
-89
| -4% | -$10.8K | 0.18% | 73 |
|
|
2016
Q4 | $305K | Sell |
2,495
-1,810
| -42% | -$221K | 0.21% | 74 |
|
|
2016
Q3 | $528K | Sell |
4,305
-690
| -14% | -$84.6K | 0.36% | 61 |
|
|
2016
Q2 | $583K | Sell |
4,995
-130
| -3% | -$15.2K | 0.42% | 58 |
|
|
2016
Q1 | $714K | Sell |
5,125
-514
| -9% | -$71.6K | 0.53% | 49 |
|
|
2015
Q4 | $1.08M | Buy |
5,639
+265
| +5% | +$50.6K | 0.8% | 27 |
|
|
2015
Q3 | $840K | Buy |
5,374
+1,475
| +38% | +$231K | 0.68% | 35 |
|
|
2015
Q2 | $705K | Buy |
3,899
+133
| +4% | +$24K | 0.57% | 41 |
|
|
2015
Q1 | $653K | Sell |
3,766
-3,548
| -49% | -$615K | 0.54% | 44 |
|
|
2014
Q4 | $1.36M | Buy |
+7,314
| New | +$1.36M | 0.65% | 41 |
|